Indefinite Delivery Contract SPE2D020D0006
Award Date
7/14/20
Last Date to Order
7/14/30
Federal Agency
Medical Supply Chain
Awardee
Hikma Pharmaceuticals USA Inc.
Ultimate Awardee
Hikma Specialty USA Inc.
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Acquisition Center, a civilian federal agency, has awarded a single-award Blanket Purchase Agreement (BPA) to Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals, for the procurement of the controlled substance sodium oxybate. The contract has a ceiling value of $38,500,000 and a period of performance through February 6, 2026. Hikma Pharmaceuticals USA Inc. is a foreign-owned, for-profit pharmaceutical manufacturer registered in the System for Award...
Hikma Pharmaceuticals USA Inc., a foreign-owned, for-profit pharmaceutical manufacturer, holds a $216 million Federal Supply Schedule contract (FSS-61-IB) with the Department of Veterans Affairs (VA) for the procurement of pharmaceuticals and drugs. This multiple-award, unrestricted Indefinite Delivery Vehicle (IDV) enables Hikma to provide a wide range of pharmaceutical products, including injectable solutions, tablets, and specialized medications, to military treatment facilities, VA...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999 single-award IDC, which is valid through March 2036, covers an extensive...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The contract covers a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal agencies. The contract, valued at $4,999,999.00, covers a wide variety of branded and generic prescription drugs, over-the-counter medications,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Under this contract, the DLA issues numerous delivery...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide. This IDC serves as the primary vehicle for Amerisourcebergen to efficiently deliver essential pharmaceutical products, medical supplies, and equipment to the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $30.9 million contract has a period of performance through March 2031 and supports the routine pharmaceutical and medical supply needs of military treatment facilities worldwide. DMS Pharmaceutical Group holds multiple DLA contracts and delivery orders to provide a wide range of products, including epinephrine...
This indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The single-award contract, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and runs through November 2026. The contract encompasses a broad array of medical commodities including specialty...
This indefinite delivery contract (IDC) was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military healthcare facilities worldwide under the TRICARE West program. Through...